TP53 and hepatocellular carcinoma: More specifically, the employment of a genome-wide clustered, regularly interspaced, short palindromic repeats (CRISPR) screen identified the anti-HCC effect of 5-azacytidine (5-aza-CR), depending on LOXL4-mediated reactivation of p53, which relays apoptosis in HCC cells.